Serum and glucocorticoid-regulated kinase 1 (SGK1) as an emerging therapeutic target for cardiac diseases

被引：2
|
作者：
Yarmohammadi, Fatemeh [1 ]
Karimi, Gholamreza [2 ,3 ]
机构：
[1] Kermanshah Univ Med Sci, Hlth Technol Inst, Med Biol Res Ctr, Kermanshah, Iran
[2] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Iran
[3] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Pharmaceut Res Ctr, Mashhad, Iran
来源：
PHARMACOLOGICAL RESEARCH | 2024年 / 208卷
关键词：
Cardiopathologic; Hippo pathway; Ion channels; NLRP3; SGK1; SIGNALING PATHWAY; HIPPO PATHWAY; GALLIC ACID; EXPRESSION; INFLAMMATION; HYPERTROPHY; FIBROSIS; MODEL; HOMEOSTASIS; POTASSIUM;
D O I：
10.1016/j.phrs.2024.107369
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Cardiac diseases encompass a wide range of conditions that affect the structure and function of the heart. These conditions are a leading cause of morbidity and mortality worldwide. The serum- and glucocorticoid-inducible kinase 1 (SGK1) is a serine/threonine kinase that plays a significant role in various cellular processes, including cell survival and stress response. Alterations in SGK1 activity can have significant impacts on health and disease. Multiple research findings have indicated that SGK1 is associated with heart disease due to its involvement in cardiac hypertrophy and fibrosis. This article reviews different signaling pathways associated with SGK1 activity in various heart conditions, including the SGK1/NF-kappa B and PI3K/SGK1 pathways.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure
    Busjahn, A
    Aydin, A
    Uhlmann, R
    Krasko, C
    Bähring, S
    Szelestei, T
    Feng, YX
    Dahm, S
    Sharma, AM
    Luft, FC
    Lang, F
    HYPERTENSION, 2002, 40 (03) : 256 - 260
  • [2] The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
    Dattilo, Vincenzo
    Amato, Rosario
    Perrotti, Nicola
    Gennarelli, Massimo
    FRONTIERS IN GENETICS, 2020, 11
  • [3] Endothelial cell serum and glucocorticoid regulated kinase 1 (SGK1) mediates vascular stiffening
    Zhang, Liping
    Sun, Zhe
    Yang, Yan
    Mack, Austin
    Rodgers, Mackenna
    Aroor, Annayya
    Jia, Guanghong
    Sowers, James R.
    Hill, Michael A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 154
  • [4] Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells
    Fagerli, U-M
    Ullrich, K.
    Stuehmer, T.
    Holien, T.
    Koechert, K.
    Holt, R. U.
    Bruland, O.
    Chatterjee, M.
    Nogai, H.
    Lenz, G.
    Shaughnessy, J. D., Jr.
    Mathas, S.
    Sundan, A.
    Bargou, R. C.
    Doerken, B.
    Borset, M.
    Janz, M.
    ONCOGENE, 2011, 30 (28) : 3198 - 3206
  • [5] Spinal Serum- and Glucocorticoid-Regulated Kinase 1 (SGK1) Signaling Contributes to Morphine-Induced Analgesic Tolerance in Rats
    Xiao, Li
    Han, Xue
    Wang, Xiao-e
    Li, Qi
    Shen, Pu
    Liu, Zhong
    Cui, Yu
    Chen, Yu
    NEUROSCIENCE, 2019, 413 : 206 - 218
  • [6] Hepatic serum- and glucocorticoid-regulated protein kinase 1 (SGK1) regulates insulin sensitivity in mice via extracellular-signal-regulated kinase 1/2 (ERK1/2)
    Liu, Hao
    Yu, Junjie
    Xia, Tingting
    Xiao, Yuzhong
    Zhang, Qian
    Liu, Bin
    Guo, Yajie
    Deng, Jiali
    Deng, Yalan
    Chen, Shanghai
    Naray-Fejes-Toth, Aniko
    Fejes-Toth, Geza
    Guo, Feifan
    BIOCHEMICAL JOURNAL, 2014, 464 : 281 - 289
  • [7] The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma
    Li, Jiao
    Yu, Hui
    Wang, Xing
    Ye, Yingying
    Fang, Wei
    Ding, Ning
    Mi, Lan
    Ping, Lingyan
    Wang, Xiaogan
    Song, Yuqin
    Zhu, Jun
    CANCER CONTROL, 2022, 29
  • [8] The physiological impact of the serum and glucocorticoid-inducible kinase SGK1
    Lang, Florian
    Artunc, Ferruh
    Vallon, Volker
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (05): : 439 - 448
  • [9] Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and γ-ray irradiation was elucidated
    Tang, Zhiyuan
    Shen, Qin
    Xie, Hao
    Zhou, Zhu
    Shi, Guanglin
    Zhang, Caixin
    Mohammed, Anaz
    Wu, Yi
    Ni, Songshi
    Zhou, Xiaoyu
    ONCOLOGY REPORTS, 2018, 39 (03) : 1505 - 1515
  • [10] Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening
    Geldenhuys, Werner J.
    Talasila, Phani K.
    Sadana, Prabodh
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) : 5675 - 5678
12345